key: cord-1014173-s3yuryq0
authors: Marmor, Michael; DiMaggio, Charles; Friedman-Jimenez, George; Shao, Yongzhao
title: Quality Improvement Tool to Rapidly Identify Risk Factors for SARS-CoV-2 Infection among Healthcare Workers
date: 2020-06-14
journal: J Hosp Infect
DOI: 10.1016/j.jhin.2020.06.012
sha: 8ee869d55a9275ad890e91b5d4f7cc344a8a9fc2
doc_id: 1014173
cord_uid: s3yuryq0

The rapid growth of the coronavirus disease 2019 (COVID-19) pandemic, limited availability of personal protective equipment, and uncertainties regarding transmission modes of the novel severe acute respiratory syndrome coronavirus - 2 (SARS-CoV-2) have heightened concerns for safety of healthcare workers (HCWs). Systematic studies of occupational risks for COVID-19 in the context of community risks are difficult and are only recently starting to be reported. Ongoing quality improvement studies in various locales and within many affected healthcare institutions are needed. We propose a template design for small-scale quality improvement surveys. Such surveys have the potential for rapid implementation and completion, are cost-effective, impose little administrative or workforce burden, can reveal occupational risks while taking into account community risks, and can be easily repeated with short intervals of time between repetitions. We describe a template design and propose a survey instrument that is easily modifiable to fit the particular needs of various healthcare institutions in the hope of beginning a collaborative effort to refine the design and instrument. These methods, along with data management and analytic techniques, can be widely useful and shared globally. Our goal is to facilitate quality improvement surveys aimed at reducing the risk of occupational infection of healthcare workers during the COVID-19 pandemic.

A critical mission of infection control programmes in healthcare institutions is to reduce the risk of occupationally-acquired infections among health care workers (HCWs).

The importance of this mission has increased along with the magnitude of the Coronavirus disease 2019 (COVID-19) pandemic. Massive surges in the numbers of hospitalized patients, evolving understanding of the novel Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2) transmissibility, limited availability of personal protective equipment (PPE), and limited availability of diagnostic testing each have contributed to concerns for inadequacies of institutional programmes for protection of HCW's health. We therefore propose a template design for quality improvement of infection control programmes in healthcare institutions in order to support these programmes' efforts to identify preventable HCW exposures and implement remedial actions.

In the absence of effective vaccines or treatments for COVID-19, protection of HCWs with consistent implementation of infection control procedures is necessary. These 5 may include, as appropriate to the clinical situation, careful hand hygiene, engineering controls (such as ventilation), administrative controls (such as planned cohorting of patients), and PPE (such as N95 face masks, gloves, gowns, face shields and goggles). Large numbers of HCW infections have been reported in many countries and adequate protection of HCWs has proven to be challenging, as reported in studies from Italy, Spain, and India.[1-3] Risk factors for incident SARS-CoV-2 infection, reported in a preprint (not yet peer-reviewed) from the United Kingdom and the United States, found significantly elevated hazard ratios among HCWs compared to the general public associated with reuse of PPE, inadequate access to PPE, and caring for COVID-19 patients even in the context of adequate access to PPE [4] . A study of 41 HCWs in Singapore (85% of whom wore surgical masks, and 15% of whom wore N95 masks) who had contact with a COVID-19 patient during a single endotracheal intubation reported that none became SARS-CoV-2 infected as a result. [5] Newspaper reports of SARS-CoV-2 infections and COVID-19 deaths among HCWs underscore health concerns. [6] [7] [8] In sum, while adequate PPE supplies and infection control guidelines are important, the quality of protections for HCWs has to be monitored and failures need rigorous and prompt investigation.

Quality improvement surveys to identify and reduce occupational risks of SARS-CoV-2 infection among HCWs are warranted. Potential risks of SARS-CoV-2 infection among HCWs that must be considered in such surveys include risks from patients, patients' visitors (if these are permitted), other HCWs, contaminated surfaces and PPE, and HCWs' non-occupational activities in the community, including commuting between work and home. That SARS-CoV-2 may be airborne transmissible means that studies need to address the possibility of dispersal of virus over longer distances, and persistence in air over greater 6 periods of time, than if transmission were solely via droplets. Persistence of the virus in places that lack adequate ventilation also must be considered. [9] Risk factors for SARS-CoV-2 infection among HCWs are likely to vary substantially among institutions and geographic areas. We therefore believe that a widely useful design should be developed for use by medical institutions as a template, and that this template design could be easily refined and improved cooperatively over time, while simultaneously being adapted and customized for specific local situations.

In the context of varying rates of growth in the numbers of COVID-19 cases in different institutions and locales, we propose the following criteria for evaluation of quality improvement study designs:

• Potential for rapid implementation and completion,

• Cost-effectiveness,

• Minimization of administrative and manpower burden required from stressed HCWs and healthcare institutions,

• Effectiveness of and potential for revealing occupational risks,

• Ease of implementation and potential for repetition to identify new risks over time and ability to identify possible slippage or inefficiency in management of known risks,

• Ease of statistical analysis,

• Ability to identify risks with modest-to-large odds ratios.

• Ability to monitor over time risks associated with well-known transmission routes, and

• Ability to utilize small numbers of subjects to identify novel, unexpected 7 transmission routes.

We propose small-scale studies that will require few incident cases because small studies can be repeated frequently over time to identify newly emergent problems and the success or failure of previous remediation efforts.

We propose a template design for quality improvement case-control surveys of HCWs' risks of SARS-CoV-2 infection. The proposed design of a small-scale case-control study seems the right choice because it satisfies each of the criteria listed above.

Within each institution, we first assume the existence of occupational health services and/or human resource departments (OHS/HR). Second, we assume that the infection control office/officer and OHS/HR of the institution will be informed expeditiously of all documented or presumed SARS-CoV-2 infections and will be able to create a list of HCWs who have ever had COVID-19. Second, we assume that OHS/HR possesses a list of all employees. Third, we assume that the list of employees who ever had COVID-19 can be concatenated with the list of all employees to create a list of at-risk, probably-uninfected potential controls. We assume adequate measures are taken in the institution to protect privacy and personal information as would be required by law. Finally, we assume that investigators conducting the proposed quality improvement studies can obtain support and cooperation from the senior administrators (in their roles as gatekeepers), OHS/HR, and information services to permit conduct of the requisite computerized matching of SARS-CoV-2-infected individuals (obtained from Occupational Health Services office) against a list of all employees (obtained from Human Resources) and transmission of email 8 invitations to potential subjects without revealing to the survey staff any names or other personal identifiers of the subjects participating in the quality improvement survey.

Cases in the quality improvement case-control surveys will be HCWs with incident COVID-19, while controls will be at-risk HCWs not known to have had COVID-19 at any time prior to enrolment in the study. Inclusion criteria for cases will be We propose that all employees who recently worked on-site at the institution be eligible for inclusion as cases or controls, irrespective of whether their duties involve contact with patients or soiled patient materials. Inclusion of employees who have not had contact with patients or soiled patient materials will allow estimation of community risks 9 and risks associated with transmission through air ducts or within shared common facilities (e.g., elevators, dining halls, hallways, restrooms).

The proposed study design can be considered a nested case control study, with the underlying, dynamic cohort being all employees in the institution. To increase statistical precision, 3 -4 or more potential controls per case will be selected at random from the list of potential at-risk controls. Controls will be randomly selected from employees who have remained COVID-19-free up to the date of each case's enrolment. Temporal-matching of control to case questionnaire responses will be attempted by sending invitations to index cases and their matched controls on the same dates. Date-matching will control for possibly important, unmeasured determinants of infection risk that may have varied strongly by calendar time, such as local prevalence of individuals shedding SARS-CoV-2, local policies and access to PPE, community access to and use of face masks, and access to SARS-CoV-2 diagnostic tests.

We estimate that two thirds of potential controls will participate, and thus base our power estimates (see below) on two-to-one matching of controls to cases (assuming invitations are sent to three controls per case). Institutions that elect to invite four or more controls for each case may achieve greater precision including more precise estimates of odds ratios.

Cases and controls will be sent email invitations to participate in the case-control study at the time that OHS/HR learns of the index, incident case infection. Emails will include a short explanation of the study and a link to an online survey created with a suitable database platform such as the REDCap data management program which is widely available 10 in US healthcare institutions. [10] The email invitation will provide options of refusing participation; accepting participation; or if the subject's health is poor, requesting postponed participation. The first paragraph of the survey instrument will contain information usually found in an informed consent form appropriate for a quality improvement survey. The survey questionnaire will be self-administered by most respondents on either a computer or smartphone. We will not interview surrogate respondents when subjects are too ill to respond themselves because we do not expect that surrogates would have the knowledge and insights needed to provide accurate answers. We suggest that cases whose health improves be allowed to participate when they are well enough if they choose to do so. Responses will be anonymous; names, telephone numbers, email addresses, and Internet Protocol addresses will not be recorded.

We have developed a sample questionnaire, building on questionnaires of the World Several examples of risk factors that can be explored with the proposed questionnaire are:

• Occupation;

• Storing a used facemask in a paper bag followed by re-use;

• Age;

• Years of experience in the current job;

• Months of experience in the COVID-19 infection control environment;

• Close quarter (< 2 m) exposures greater than 10 minutes to asymptomatic co-workers who are not wearing face coverings;

• Close quarter exposure to a patient talking without a mask on;

• Failure to wear a mask in hallways outside patients' rooms.

In developing the proposed questionnaire, a challenge was the identification of the relevant time span of behaviours that may have caused infection with SARS-CoV-2.

Behaviours may change after onset of symptoms. Symptoms have been reported to appear anywhere from four to 14 days after infection. We estimate zero to six days may pass between onset of symptoms and employee evaluation by the occupational health service, at which time an invitation to participate in the survey will be emailed to the potential case.

We therefore have chosen to ask for average behaviours in the seven-day period from four to 11 days prior to either onset of symptoms, or (for those who experienced no symptoms) sample donation resulting in the subject's first positive COVID-19 test result. For controls,

we ask for average behaviours in the period seven to 14 days prior to interview. 12 Investigators adopting our template study design can modify the template questionnaire to fit local epidemic conditions.

As mentioned above, the quality improvement survey and the present template protocol could be mounted on a journal's or academic institution's website and opened for refinement and use by health institutions and investigators. The template questionnaire is included in the appendix; it can be modified by investigators based on local institutional needs.

The proposed case-control approach is designed to use very limited numbers of participants to provide rapid estimates of potentially strong associations that could quickly Data analyses for the proposed template study can be conducted using classical 13 categorical techniques and conditional logistic regression or Cox regression for nested casecontrol studies.

We propose to include in the survey form open-ended questions on how participants believe they became infected, why they believe they have remained uninfected, and risky situations or behaviours they have observed. These responses could provide the basis for interventions even in the lack of corresponding data from a comparison group, as would be required for statistical analysis. Behaviours or situations may pose risks that are obvious enough that they should be remediated without a need for a demonstrated, statistically significant association with infection, much as it has long been recognized that some measures for the prevention of adverse health outcomes do not require clinical trials. [13] Responses to the open-ended questions also might provide insights that could be used to modify the survey form in the future.

In the situation of 20 HCW infections, and a control group of 40 uninfected controls, the study could detect odds ratios of 5.0 or greater for a risk factor present in 20% of controls at an alpha level of significance of 0.05 and power of 80% . [14] A retrospective study of HCWs involved with patients requiring intubation during the Toronto 2003 SARS-CoV-1 epidemic in Toronto, found several risk factors with odds ratios >5. 6 The detected risk factors that are easily addressed would be corrected even if their odds ratios (estimating the strengths of association) had wide confidence interval due to small sample sizes. The aim of this survey and data analysis is to rapidly identify strong effects of possibly preventable exposures so remediation can begin promptly. Larger sample sizes could be 14 accrued in large institutions. Analyses using small numbers of participants, however, might be preferable because they could be repeated within a healthcare system every few weeks, depending on numbers of new cases, to capture changing risks. The small sample size investigation also can generate useful data and hypotheses to be used to design more comprehensive research.

The clinical, practical, or administrative uses for these measurements are intended to 

Possible limitations of the proposed quality improvement studies include:

• Odds ratios will be biased towards the null if many controls are in fact SARS-CoV-2 infected, but asymptomatic or in early stages of disease during which antigen and antibody may be undetectable.

• Participation rates, especially among controls may be low if COVID-19 patient loads are high, emotional and physical exhaustion are common, and HCWs are being asked to participate in numerous other studies. We expect HCW interest in the study, however, and do not anticipate that findings will be biased substantially due to poor participation.

Quality improvement studies like those we propose can reduce COVID-19 infections of HCWs, thereby protecting the general population from the risks associated with loss of HCWs due to illness and death. The payoffs for the public will be at least two-fold: first, in the greater availability of healthcare personnel needed by the public during the pandemic, and second in the lessened chance of healthcare personnel unknowingly spreading disease to patients, co-workers and community contacts in the absence of high quality protection of HCWs. With modifications the template study design and questionnaire we propose could be applied to other industries, such as meatpacking, warehousing or transit, where risky conditions or behaviours appear to be resulting in excess SARS-CoV-2 infections.

The proposed study design scores well on our criteria for template designs. We have suggested steps to be followed in conducting the study both in outline (Table 1) and flowchart formats ( Figure 1 ). The design can be rapidly implemented and the study completed if the SARS-CoV-2 infection rate is high, particularly in institutions with large numbers of employees. Participation rates and rapidity of implementation will be enhanced by the anonymous nature of the surveys and the quality improvement purpose of the study, obviating the need for delays associated with submission to institutional review boards unless research teams choose to view the investigations as research projects. Financial resources required would be modest, as the standardized survey can be developed using 16 REDCap or similar platforms and made available as open source code, subjects will do their own data entry, and data analysis will use simple categorical or logistic regression methods.

Administrative burdens will be limited to time incurred by collaborating individuals in OHS/HR. The studies will have adequate power to reveal strong occupational risks, should they exist, may point towards risks with elevated but imprecisely estimated odds ratios, and via qualitative, free-text responses may identify previously unrealized but dangerous situations where immediate remediation may be required. 1) Decide that a quality improvement study is warranted due to concern that current institutional protection against SARS-CoV-2 infections among HCWs may be inadequate.

2) Organize study and adapt to local situation: Adapt template study design to local situation; modify/translate the questionnaire as needed. Assign responsibility for: (1) identification of cases and controls; (2) distribution of invitations to potential participants; (3) regular monitoring of incoming data;. and (4) Monitor incoming data (especially free-text responses at least weekly to spot obvious risks, especially in free-text responses.

Ask at each monitoring data inspection, "Have respondents identified obvious risks requiring immediate investigation?"

Promptly inform infection control office and responsible officials of findings, needs for further investigation, and recommendations.

Analyze and interpret data in light of current evidence on SARS-CoV-2 transmission

Promptly inform infection control office and responsible officials of study findings, needs for further investigation, and recommendations.

Is additional study needed (e.g., suspected ongoing preventable transmission)?" Store data and study manuals of procedures for possible future use.

Report findings and recommendations to institutional infection control office or officer for possible QI action for better protection of HCWs.

Revise questionnaire and procedures as necessary.

Continue accruing data until planned number of subjects are accrued.

Repeat the QI study

The daunting experience of healthcare workers in

McKee M The resilience of the Spanish health system against the COVID-19 pandemic

Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19

Risk of COVID-19 among frontline healthcare workers and the general community: a prospective cohort study. medRxiv 2020.04.29

and the Risk to Health Care Workers: A Case Report

Nurses Who Can't Get Tested Fear They Are Spreading COVID-19

Hospital Workers on LI Contracting Virus

Thousands of US Health Care Workers Have Been Infected by the

Protecting healthcare workers from SARS-CoV-2 infection: practical indications

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support

Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto

Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials

Determining when quality improvement initiatives should be considered research: proposed criteria and potential implications

World Health Organization. Ethical standards for research during public health emergencies: Distilling existing guidance to support COVID-19 R&D